258 related articles for article (PubMed ID: 11247290)
1. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
[TBL] [Abstract][Full Text] [Related]
2. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
4. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
[TBL] [Abstract][Full Text] [Related]
5. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
8. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
[TBL] [Abstract][Full Text] [Related]
9. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Wagner S; Haruma K; Gladziwa U; Soudah B; Gebel M; Bleck J; Schmidt H; Manns M
Am J Gastroenterol; 1994 Aug; 89(8):1211-8. PubMed ID: 8053437
[TBL] [Abstract][Full Text] [Related]
11. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
Osumi H; Fujisaki J; Suganuma T; Horiuchi Y; Omae M; Yoshio T; Ishiyama A; Tsuchida T; Miki K
PLoS One; 2017; 12(8):e0183980. PubMed ID: 28854276
[TBL] [Abstract][Full Text] [Related]
12. Duodenal erosions after eradication of Helicobacter pylori infection.
Shiotani A; Nishioka S; Iguchi M; Yanaoka K; Okada K; Tamai H; Mantani Y; Itoh H; Graham DY
Gastrointest Endosc; 2001 Oct; 54(4):448-53. PubMed ID: 11577305
[TBL] [Abstract][Full Text] [Related]
13. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.
Iijima K; Koike T; Abe Y; Ara N; Uno K; Imatani A; Ohara S; Shimosegawa T
J Gastroenterol; 2009; 44(8):819-25. PubMed ID: 19440811
[TBL] [Abstract][Full Text] [Related]
14. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
[TBL] [Abstract][Full Text] [Related]
15. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
17. Association of serum pepsinogens and gastrin-17 with
Zhou JP; Liu CH; Liu BW; Wang YJ; Benghezal M; Marshall BJ; Tang H; Li H
Front Cell Infect Microbiol; 2022; 12():980399. PubMed ID: 36051244
[TBL] [Abstract][Full Text] [Related]
18. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Pérez-Paramo M; Albillos A; Calleja JL; Salas C; Marín MC; Marcos ML; Cacho G; Escartín P; Ortiz-Berrocal J
Dig Dis Sci; 1997 Aug; 42(8):1734-40. PubMed ID: 9286242
[TBL] [Abstract][Full Text] [Related]
19. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection.
Watanabe H; Hiraishi H; Ishida M; Kazama JJ; Terano A
J Intern Med; 2003 Nov; 254(5):439-46. PubMed ID: 14535965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]